Apyx Medical Corporation (Clearwater, FL) announced it has obtained regulatory approval to market and sell its Helium Plasma Technology products in five new countries: Australia, Brazil, Israel, Taiwan and Thailand. The company said it has contracted with distributors to market and sell its products in each country.
“We are very pleased to obtain regulatory approvals to market and sell our Helium Plasma Technology products in these five new countries.” said Charlie Goodwin, President and CEO. “…This strategy is based on the prudent expansion of our commercial footprint outside the U.S. by securing the requisite product registrations for our Helium Plasma Technology products, and identifying strong distribution partners in each respective market… We shipped an initial commercial order to our distributor in Brazil in late-June and we expect to ship our initial commercial orders to each of the other new countries over the second half of 2020…”